alpha-Synuclein protofibrils inhibit 26 S proteasome-mediated protein degradation: understanding the cytotoxicity of protein protofibrils in neurodegenerative disease pathogenesis
- PMID: 18502751
- DOI: 10.1074/jbc.M710560200
alpha-Synuclein protofibrils inhibit 26 S proteasome-mediated protein degradation: understanding the cytotoxicity of protein protofibrils in neurodegenerative disease pathogenesis
Abstract
The impaired ubiquitin-proteasome activity is believed to be one of the leading factors that contribute to Parkinson disease pathogenesis partially by causing alpha-synuclein aggregation. However, the relationship between alpha-synuclein aggregation and the impaired proteasome activity is yet unclear. In this study, we examined the effects of three soluble alpha-synuclein species (monomer, dimer, and protofibrils) on the degradation activity of the 26 S proteasome by reconstitution of proteasomal degradation using highly purified 26 S proteasomes and model substrates. We found that none of the three soluble alpha-synuclein species impaired the three distinct peptidase activities of the 26 S proteasome when using fluorogenic peptides as substrates. In striking contrast, alpha-synuclein protofibrils, but not monomer and dimer, markedly inhibited the ubiquitin-independent proteasomal degradation of unstructured proteins and ubiquitin-dependent degradation of folded proteins when present at 5-fold molar excess to the 26 S proteasome. Together these results indicate that alpha-synuclein protofibrils have a pronounced inhibitory effect on 26 S proteasome-mediated protein degradation. Because alpha-synuclein is a substrate of the proteasome, impaired proteasomal activity could further cause alpha-synuclein accumulation/aggregation, thus creating a vicious cycle and leading to Parkinson disease pathogenesis. Furthermore we found that alpha-synuclein protofibrils bound both the 26 S proteasome and substrates of the 26 S proteasome. Accordingly we propose that the inhibitory effect of alpha-synuclein protofibrils on 26 S proteasomal degradation might result from impairing substrate translocation by binding the proteasome or sequestrating proteasomal substrates by binding the substrates.
Similar articles
-
beta-Synuclein reduces proteasomal inhibition by alpha-synuclein but not gamma-synuclein.J Biol Chem. 2005 Mar 4;280(9):7562-9. doi: 10.1074/jbc.M412887200. Epub 2004 Dec 9. J Biol Chem. 2005. PMID: 15591046
-
α-mangostin derivative 4e as a PDE4 inhibitor promote proteasomal degradation of alpha-synuclein in Parkinson's disease models through PKA activation.Phytomedicine. 2022 Jul;101:154125. doi: 10.1016/j.phymed.2022.154125. Epub 2022 Apr 25. Phytomedicine. 2022. PMID: 35525236
-
Aggregated and monomeric alpha-synuclein bind to the S6' proteasomal protein and inhibit proteasomal function.J Biol Chem. 2003 Apr 4;278(14):11753-9. doi: 10.1074/jbc.M208641200. Epub 2003 Jan 24. J Biol Chem. 2003. PMID: 12551928
-
Role of Ubiquitin-Proteasome and Autophagy-Lysosome Pathways in α-Synuclein Aggregate Clearance.Mol Neurobiol. 2022 Sep;59(9):5379-5407. doi: 10.1007/s12035-022-02897-1. Epub 2022 Jun 14. Mol Neurobiol. 2022. PMID: 35699874 Review.
-
Aggregopathy in neurodegenerative diseases: mechanisms and therapeutic implication.Neurodegener Dis. 2008;5(6):321-38. doi: 10.1159/000119459. Epub 2008 Feb 29. Neurodegener Dis. 2008. PMID: 18309232 Review.
Cited by
-
Pathogenic Impact of Fatty Acid-Binding Proteins in Parkinson's Disease-Potential Biomarkers and Therapeutic Targets.Int J Mol Sci. 2023 Dec 1;24(23):17037. doi: 10.3390/ijms242317037. Int J Mol Sci. 2023. PMID: 38069360 Free PMC article. Review.
-
When It Comes to an End: Oxidative Stress Crosstalk with Protein Aggregation and Neuroinflammation Induce Neurodegeneration.Antioxidants (Basel). 2020 Aug 12;9(8):740. doi: 10.3390/antiox9080740. Antioxidants (Basel). 2020. PMID: 32806679 Free PMC article. Review.
-
Pale body-like inclusion formation and neurodegeneration following depletion of 26S proteasomes in mouse brain neurones are independent of α-synuclein.PLoS One. 2013;8(1):e54711. doi: 10.1371/journal.pone.0054711. Epub 2013 Jan 30. PLoS One. 2013. PMID: 23382946 Free PMC article.
-
Cross-talk between mitochondria and proteasome in Parkinson's disease pathogenesis.Front Aging Neurosci. 2010 May 21;2:17. doi: 10.3389/fnagi.2010.00017. eCollection 2010. Front Aging Neurosci. 2010. PMID: 20577640 Free PMC article.
-
Distinct roles in vivo for the ubiquitin-proteasome system and the autophagy-lysosomal pathway in the degradation of α-synuclein.J Neurosci. 2011 Oct 12;31(41):14508-20. doi: 10.1523/JNEUROSCI.1560-11.2011. J Neurosci. 2011. PMID: 21994367 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical